FDA clears device that treats diabetic foot ulcers for market

[Image from Sanuwave]

The FDA announced today that it has cleared the Dermapace System diabetic foot ulcer treatment device for market.

Dermapace System, created by Sanuwave, is the first shockwave device to treat foot ulcers caused by diabetes.

“Diabetes is the leading cause of lower limb amputations,” Binita Ashar, director of the division of surgical devices in FDA’s Center for Devices and Radiological Health, said in a press release. “The FDA is dedicated to making technologies available that can help improve the quality of life for those with chronic diseases. Additional options for successfully treating and healing ulcer wounds may help prevent lower limb amputations.”

Get the full story on our sister site, Medical Design & Outsourcing.

The post FDA clears device that treats diabetic foot ulcers for market appeared first on MassDevice.

from MassDevice http://ift.tt/2C6j8Iq